TAFAZZIN and obesity disorder: In both cases of TAZ-KD and no PE N-methyltransferase activity, hepatocytes showed metabolic signs of elevated protection against diet-induced obesity and insulin resistance (van der Veen et al, 2014; Cole et al, 2016).